Electronic System Reminds Patients to Schedule Exams

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 16 No 4
Volume 16
Issue 4

A computerized mail and phone reminder program managed by appointment secretaries significantly increased the percentage of patients undergoing annual mammography at the Mayo Clinic

ROCHESTER, Minnesota—A computerized mail and phone reminder program managed by appointment secretaries significantly increased the percentage of patients undergoing annual mammography at the Mayo Clinic, according to a study by Rajeev Chaudhry, MBBS, MPH, and colleagues (Arch Intern Med 167:606-611, 2007).

The researchers randomized 6,665 women age 40 to 75 to usual care or to an intervention group that received mailings (two monthly letters starting 3 months before they were due for screening) followed by a phone call to nonresponding patients, to remind them to schedule a mammogram.

Among the reminded group, 64.3% had their annual mammogram vs 55.3% of controls (P < .001). There were no significant differences between the two groups for any of the other adult preventive services. A subgroup that also received an email reminder had a 72.2% compliance rate. As the program has expanded following the study period, compliance has now grown to more than 72%, Dr. Chaudhry said, with 86% having had one exam within the previous 2 years.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.
Related Content